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Abstract 
Decreasing in quantity and quality of land including available land for crop cultivations leads to many 
efforts to develop appropriate technology for genetic improvement through biotechnology approach. A 
novel trending tools to perform genetic modification intensively discussed is genome editing, which is 
developing rapidly. By applying genome editing, many researches have been performed successfully to 
improve the genetic trait of organism by modification of DNA with no traces of foreign gene in the final 
products. There are research reports concerning the development of climate-compatible crops, high 
productivity, high quality and specific trait for animals and fish, effective and specifically targeted biocat-
alytic processes by using microorganism, health-promoting foodstuffs and environmentally friendly pro-
duction using genome editing approach. The genome editing approach will be an important alternative 
for modern breeding, which is different to the existing GMO technologies, which has already been devel-
oped for almost 30 years. Many assessments concluded that genome editing will catalyze important in-
novations in the bioeconomy. This paper will discuss about the global trends of genome editing and the 
opportunity and challenge faced in Indonesia. Moreover, it will also discuss the roles of the existing regu-
lations and how they adapt to respond to this new technology.  
 




Nowadays, the world needs novel technology capable of solving a number challenges such 
as decreasing environmental quality, global warming, population (number and health quality) 
issues, deceasing number and quality of land for crops, emerging diseases and providing green 
energy (biofuel) [34]. One of the important driving tools is the development of efficient and 
environmentally friendly method by using modern biotechnological approach for supporting 
food and energy resiliency, environmentally friendly biomaterial products, pharmaceutical 
products, cleaner technology processes, fine chemicals, biocatalyst as well as vaccine for emerg-





1 Corresponding author.  
Tel. : +62-85216069001 
E-mail : bambang.prasetya@gmail.com  
Main contributor : Bambang Prasetya, Satya Nugroho 
Published in May 2021, http://publikasikr.lipi.go.id/index.php/satreps 




Based on the International Advisory Committee on Bioeconomy Summit held in Berlin in 
November 2015, bioeconomy is defined as “knowledge-based production and utilization of bio-
logical resources, biological processes and principles to sustainably provide goods and services 
across all economic sectors”. Bioeconomy involves three elements, firstly the utilizations of re-
newable biomass and efficient bioprocesses to achieve sustainable productions. Secondly, ena-
bling and converging technologies of nano technology, biotechnology and information technol-
ogy. Beyond biotechnology, a key development is the combination of digitalization and ‘biologi-
zation’. Sustainable development is supported by applications, such as precision agriculture, sat-
ellite forestry monitoring, DNA barcoding of species, etc. In the IT industry, biological knowledge 
is applied to computer and chip designs, e.g. DNA data storages. Moreover, bioeconomy also 
concerns about the integration across applications, involving primary production regarding all 
living natural resources, industry (involving chemicals, plastics, enzymes, pulp and paper, bioen-
ergy) and health care including pharmaceuticals and medical devices [21].  
In this review 52 referred scientific papers, review papers, policy papers and online pub-
lication on biodiversity and their potential contribution to economy, and the application of ge-
nome editing to improve economically important crops, were used to perform the analyses of 
the importance of genome editing to support the acceleration of the acquirement of the full 
benefit of biodiversity by the implementation of bioeconomy in Indonesia. The method used in 
this review is based on descriptive analysis and on results of some expert group discussions con-
cerning genome editing, The importance of the application of modern technology, such as ge-
nome editing, in harnessing the full potential of bioeconomy were analyzed by looking at the 
significant increase numbers of published papers on the application of genome editing for vari-
ous crops improvements in the recent years, and the adoption of such technology by many pub-
lic and private institutions. 
2. Genome Editing and Its Implementation 
a. Genome Editing 
The developments of molecular biology is based on the discovery of DNA. (Deoxyribo-
Nucleic-Acid) by Oswald Avery in 1944 and followed by the revelation of the X- ray diffraction 
images of DNA by Rosalind Franklin, which were the bases of the discovery of double helix DNA 
by Francis Crick, James Watson, and Maurice Wilkins. DNA is a molecule composed of two poly-
nucleotide chains that coil around each other to for a double helix carrying genetic instructions 
for the development, functioning, growth and reproduction of all known organisms. The devel-
opment of techniques for DNA modification have enabled many advances in biology and lead to 
rapid development of biotechnology. Initiated with the development of chemical methods for 
solid-phase DNA synthesis and culminating in the enabling detection and exploration of genome 
of organisms. Many techniques in molecular biology have provided tools to isolate genes and 
gene fragments, as well as to introduce mutations into genes in vitro, in cells, and in model 
organisms. This knowledge in combination with genomic sequencing technologies which can 
provide whole-genome sequencing data for diverse organisms, including humans, has acceler-
ated the development of DNA modification technology including DNA recombinant technology 
for many different purposes. The continuing research and development to find out the effective 
method for modification of DNA indicate that genome editing technology, which was intensively 
developed in the last decade will bring breakthrough in molecular biology [19].  
Out of four existing nuclease-based gene editing strategies (meganuclease, zinc finger 
protein (ZFN), transcription activator-like effector protein (TALEN) and CRISPR-Cas9), the 




CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats- CRISPR- associated), 
has become more popular due to its ease of application and economic considerations as a low-
cost technology [6]. CRISPR is a repetitive DNA sequence found in bacteria and archaea that will 
be transcribed into crRNA (CRISPR RNA). This technology works when the crRNA structure acts 
as a mechanism to defend themselves from foreign virus or plasmid by detecting the presence 
of viruses that have previously infected them. Bacteria and archaea have the ability to record 
the viral sequence by incorporating them in their genome in the form of repetitive sequence, 
which will be used to recognize the presence of virus in the future. Upon recognition by crRNA 
directions, to target the virus, the bacteria send the Cas9 protein to cut the viral DNA in the form 
of double strand breaks. 
This repair mechanisms of the double strand breaks leads to two possibilities, the first is 
non- homologous end joining (NHEJ) that will result in a mutation in the DNA that may cause 
gene silencing, which is known as site directed nuclease I (SDN I). Or by homology directed re-
combination (HDR) by using surrounding DNA as template to create insertion to the invaded 
strand, which was known as SDN II and SDN III, depending in the extent of the newly inserted 
DNA fragments. Using the second possibility, scientists can create their own final arrangement 
to customize the target DNA to suite their purpose [17]. Figure 1 and 2 showed the mechanism 
of gene editing using the CRISPR-Cas9 [30]. Table 1 shows the various techniques in gene modi-
fication, including genome editing [23]. 
 
 
Figure 1. Mechanism of gen editing using CRISPR-Cas9 






Figure 2.  Schematic representation of the mechanism by which CRISPR-Cas9 recognizes and 
targets DNA for cleavage. Binding of sgRNA leads to a large conformational change in 
Cas9. In this activated conformation, the PAM-interacting cleft (dotted circle), 
becomes pre- structured for PAM sampling, and the seed sequence of sgRNA is 
positioned to interrogate adjacent DNA for complementarity to sgRNA. The process 
starts with PAM recognition, which in the next step leads to local DNA melting and 
RNA strand invasion. There is a step- wise elongation of the R-loop formation and a 
conformational change in the HNH domain to ensure concerted DNA cleavage. 
Abbreviations: bp, base pair; NUC, nuclease lobe; PAM, protospacer adjacent motif; 
REC, recognition lobe; sgRNA, single-guide RNA. 
 
Table 1. Techniques in gene modification [23] 
 Type of New Genetic Modification 
Techniques 
New Genetic Modification Techniques 
A Genome editing with site- directed 
nucleases (SDN) 
CRISPR-based systems for genome editing 
(CRISPR) 
  TALE-directed Nuclease systems for genome 
editing (TALEN) 
  Zinc-Finger-directed Nuclease systems for 
genome editing (ZFN) 
B Genome editing directed by 
oligonucleotides 
Oligonucleotide-directed Mutagenesis (ODM) 
  Multiplex Automated Genomic Engineering 
(MAGE) 
C Modification of gene expression RNA-directed DNA Methylation (RdDM) 
D Variants of GM technology Cisgenesis (CG) / Intragenesis (IG) 
  Transgrafting (TG) 
E Breeding support techniques Agro-infiltration (AI) 
  Haploid Induction (HI) 
  Reverse Breeding (RB) 




b. Trend of research on genome editing and its implementation. 
Since gene editing using the CRISPR-Cas9 system is known as promising tools in genetic 
engineering due to its simplicity and high efficiency, there have been many genomes editing 
supported research and development in various organisms targeting different traits. CRISPR-
Cas9 has now been utilized widely to edit the genome of various organisms, including bacteria, 
yeast, plants and animals [47]. In the medical field, genome editing, has the potential to both 
improve the understanding of human genetics and cure genetic diseases [20]. 
 
Table 2. Landscape of publications on genome editing [23]  
 
Genome Editing 
RdDM CG IG TG 
Support 
breeding 








114 8 7 1 1 1 2 4 23 4 7 
SDN−1 99 5 4 - n.a.  n.a. n.a. n.a. n.a. n.a. n.a. 
SDN−2 5  - - n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
SDN−3 4 3 3 1 n.a n.a n.a n.a n.a n.a n.a 
Base editing 4 - - - n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
Other types of 
genome editing 
2 -  - - n.a n.a n.a n.a n.a n.a n.a 
Method 
development  
72 1 2 1 - - 1 1 6  3 
Basic research 22 1 2 - - - - - 7 4 1 
Applied 
development 
20 6 3 - 1 1 1 3 10  2 
SDN, site-directed nuclease; CRISPR, CRISPR (Clustered regularly interspaced short palindromic repeat)-directed nu-
clease; TALEN, Transcription activator-like effector nuclease; ZFN, Zinc-Finger-directed nuclease; MN, Meganucle-
ases; ODM, Oligonucleotide-directed mutagenesis; RdDM, RNA dependent DNA methylation; CG, Cisgenesis; IG, In-
tragenesis; TG, Transgrafting; AI, Agro-infiltration; HI, Haploid induction; Other types of genome editing: different 
variants of CRISPR-based genome editing, including use of nickases; n.a.: not applicable. 
* For the use of CRISPR-based systems for genome editing and transgrafting literature was only screened for the time 
period Jan. 2016-June 2017. Bold values indicate total numbers of publications for individual nGMs for the indicated 
time periods. 
 
In plants, it has also been reported to successfully and specifically edit the genome in 
plants [11]. Application of genome editing in Arabidopsis thaliana, Nicotiana benthamiana,, rice, 
wheat, sorghum , maize and tomato indicated that the system was effective [25]. In Indonesia, 
Santoso et al. [39] reported a successful gene editing in the Kitaake cultivar model using CRISPR-
Cas9 technology. As shown in the Table 2 the application of CRISPR-Cas9 in crop breeding was 
reported in at least 37 publications which were released between 2017 to 2019. Table 2 also 
shows that genome editing using CRISPR-Cas9 system is the most published research compared 
to the other system such as TALEN and other DNA modification systems. There was a change in 
preferences as shown in Table 2 that the-five years publication from January 2011 to December 
2015 on genome editing were dominated by ZFN and TALEN system, while from January 2016 
to June 2017, CRISPR-Cas9 dominated with 114 publications [23]. The CRISPR-Cas9 system is 
already implemented in various plants (Table 3). Application of CRISPR-Cas9 in rice alone have 
been reported to target various traits, such as enhanced salinity tolerance, defective synthesis 




of chlorophyll and tiller-spreading phenotypes, enhance a higher proportion of long chains in 
amylopectin, blast resistance, bacterial blight resistance, herbicide resistant, grain number, 
thermo-sensitive genic male sterility, dense erect panicles, and larger grain size, respectively 
(Table 4) [22]. 
 
Table 3. The Number of publications related to CRISPR-Cas9 in various plants [22]  
No Crop Species Number Publication Groups 
1 Maize 1 Monocotyledon 
2 Sorghum 1 Monocotyledon 
3 Wheat 3 Monocotyledon 
4 Rice 10 Monocotyledon 
5 Banana 2 Monocotyledon 
6 Camelina sativa 1 Dicotyledon 
7 Arabidosis thaliana 2 Dicotyledon 
8 Tomato 9 Dicotyledon 
9 Potato 1 Dicotyledon 
10 Cucumber 1 Dicotyledon 
11 Soybean 1 Dicotyledon 
12 Grape 1 Dicotyledon 
13 Orange 1 Dicotyledon 
14 Grapefruits 2 Dicotyledon 
15 Mushroom 1 Fungus 
 
Table 4. Application of CRISPR-Cas9 in rice for various trait target [22] 
No Target Trait Target Gen Role Modification Reference 
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In term of research fields there are around 72 publications dealing with method develop-
ments, 22 publications on basic researches and 20 publications on applications and develop-
ments. The types of the targeted mutation by using the CRISPR-Cas9 system were classified into 
SDN 1 (99 publications), SDN 2 (5 publications) and SDN 3 (4 publications), which indicates the 
current preference and aim of the studies [23]. This report and trend of utilization method would 
be important information, especially for the benchmarking and assessment for a formulation of 
regulations. 
 
c. Trends of regulation in Genome Editing. 
Global consensus of biosafety for genetic engineering product is mainly based on the Car-
tagena Protocol on Biosafety which was adopted on 29 January 2000 and entered into force on 
11 September 2003. It is an international treaty that governs the transfer, handling, and use of 
genetically modified organisms (GMO) [37]. On international food standard, the Codex Alimen-
tarius Commission of the FAO/WHO in 2003 adopted a set of "Principles and Guidelines on foods 
derived from biotechnology" to help countries coordinate and standardize regulation on GM 
food to help ensure public safety and facilitate international trade. The guideline on import and 
export of food were updated in 2004 [15]. Because genome editing was established approxi-
mately one and half decades after the recombinant DNA technology was developed and imple-
mented, there are still open debates about the regulations. Until now, many countries are re-
vising and drafting regulations for GMO and genome-editing products with due observance of 
regulations in force in other countries, especially the United States, Canada, Australia, the Euro-
pean Union, Argentina and Brazil. However, only EU countries categorize all genome editing 
products as PRGgenetically modified [36], [24], [41]. 
El-Mounadi et al. [22] summarized the regulation of genetically modified and genome ed-
ited plants across countries as shown in Table 5. According to this report countries, such as USA, 




Australia and Japan which conduct regulation on GMO, decided not to regulate genome edited 
product. Argentina, Brazil and Chile implement partial regulation but mostly do not regulate 
genome editing products. Canada, European Union, India, Malaysia, Mexico, New Zealand, 
South Africa and Thailand belong to countries which regulate both GMO and genome editing 
products, although debates and reassessment of this regulations are still being done to gain the 
best solution. The issues on concerns related to the current regulatory approach, policy devel-
opment regarding new genetic modification (nGM) (mostly based on genome editing), and focus 
of policy amendments are shown in the Table 6 [24]. As an additional information it is also re-
ported about current experiences with nGM applications. 
 





1 Argentina Regulated Case-by-case, mostly non-
regulated 
2 Australia Regulated Non-regulated 
3 Brazil Regulated Case-by-case, mostly non-
regulated 
4 Canada Regulated Regulated 
5 Chile Regulated Case-by-case, mostly non-
regulated 
6 European Union Regulated/opposed Regulated/opposed 
7 India Regulated Regulated 
8 Japan Regulated Non-regulated 
9 Malaysia Regulated Regulated 
10 Mexico Regulated Regulated 
11 New Zealand Regulated Regulated 
12 South Africa Regulated Regulated 
13 Thailand Regulated Regulated 
14 United States of 
America 
Regulated Non-regulated 
*)  Refers to the final product containing transgenes, such as selection markers or other form of foreign DNA used 
during the process. 


























Focus of Policy 
Amendme nts 





cific types of nGMs are 
subject to GMO legis-
lation 
No amendment of Di-
rective 2001/18/EC pro-
posed by Europ. Com-
mission, but Europ. 
Court of Justice ruled 
that directed mutagen-
esis is subject to GMO 
legislation (ECJ 2018) 
 No experience on European 
level with applications for 
unconfined release and plac-
ing on the market; however 
field trials with some nGM 
applications are conducted 
(SAM, 2017) 
Argentina Determination if nGM 
product is subject to 
GMO legislation 
Supplementary resolu-
tion adopted 2015 




 Until June 2018 12 requests 
were evaluated according to 
Resolution No. 173/2015, 
incl. 10 applications of ge-
nome editing, mostly in 
plants, mostly not regulated 
(OECD, 2018) 
Australia Determination if nGM 
process is subject to 
GMO legislation 
OGTR proposed tech-





No applications for uncon-
fined release; field trials with 
some nGM applications are 
conducted 
Brazil Determination if nGM 
product is subject to 
GMO legislation 
Supplementary resolu-
tion adopted in January 
2018 (Normative Reso-
lution No 16) compara-
ble to supplementary 
regulation in Argentina) 
 Use of nGMs in contained 
use facilities; two yeast lines 
modified by genome editing 
were evaluated according to 
Resolution No 16 (not regu-
lated) 
Canada Determination if indi-
vidual nGM product is 
novel 
Review of risk assess-
ment requirements ini-
tiated 
 Several applications author-
ized (e.g., cisgenic potato, 
genome edited oilseed rape) 
New Zea-
land 
GMO legislation is cur-
rently applied for all 
nGMs 
Government adopted 
policy to direct tech-






empts chemical or 
radiation induced 
mutagene sis 
Use of nGMs for research 
and development activities; 
some genome editing deter-
mined to be regulated 
Norway Determination if spe-
cific types of nGMs are 
subject to GMO legis-
lation 
Technical discussions to 
inform further steps 
(following EU approach) 
 No applications for uncon-
fined release submitted 
South Af-
rica 
GMO legislation is cur-
rently applied for all 
nGMs 
Discussion on policy 
amendment ongoing 
 No applications for uncon-
fined release submitted; use 





cific types of nGMs are 
subject to GMO legis-
lation 
Stakeholder discussions 
to inform future policy 
 No applications for uncon-
fined release; field trials with 
some nGM applications are 
conducted 
USA Determination if indi-
vidual nGM product is 
regulated 
Consultations on policy 
to deregulate certain 
techniques (e.g., cisgen-
esis) 
 Several decisions to exempt 
nGM applications from regu-
lation; a number of nGM ap-









3. Significance Technology Genome Editing for boosting Bioeconomy 
To support the bioeconomy, biotechnology plays a key role and used as the basis for nu-
merous processes for the production of food and feed, pharmaceuticals, chemical products and 
bioenergy. The scopes of processes are developed from time to time due to innovation in meth-
odologies. Recombinant technology, which already existed for around three decades show the 
significant achievement in many fields of processes. Some conventional processes have been 
improved in genetic breeding in plants, animals, as well as microorganisms. Through protein 
recombinant technology (genetically modified organism, GMO), bioeconomy in many sectors 
have been developed and colorization in the global market. The global genetically modified or-
ganism’s food market will grow at a compound annual growth rate (CAGR) of 3.2% by the end 
of 2021. The production of genetically modified crops will increase from 112 million tons in 2015 
to 130 million tons in the year of 2021 [51]. 
The World Economic Forum (WEF) estimates that the potential revenue for new business 
opportunities in the biomass value chains could globally amount to about USD 295 billion by 
2020, that is three times the amount of 2010. In health, the value of the drug trade will also 
increase. Value of biochemicals products (other than drugs) will jump from 1.8% in 2005 to be-
tween 12% and 20% by 2015. Biofuel production is shifting away from G1 ethanol based on 
starch (starch) or cane sugar to ethanol G2 from such lignocellulosic biomass grass and wood. 
By 2030, it is estimated that biotechnology products will be more developed both in terms of 
quantity and quality, and also variant. Moreover, it estimated biotechnology could contribute 
up to at least 2.7 percent of GDP by 2030 [26]. 
Recently, genome editing has made an impact in plant engineering, including easier and 
more efficient in editing of a wider range of plants. Therefore, these applications have clear 
economic implications, with opportunities for crop improvements (e.g. drought tolerance, pest 
resistance, higher yields) as a major driver. CRISPR-Cas9 has the potential to greatly expand basic 
knowledge about the links between genotypes and phenotypes in plants. Previously, studies 
largely depended on mutagenized plants or transposon libraries, which have to be bred for many 
generations to reliably isolate a gene or mutation of interest. Expression studies can be done by 
overexpression and gene knock down facilitated by the RNAi technology, which are not as accu-
rate or reliable as genome editing by CRISPR-Cas9. Multigenic traits (those that depend on mul-
tiple genes) have been particularly challenging to study. Improved knowledge of this basic biol-
ogy is likely to expand the types of traits that can be engineered. In animal breeding, a wide 
range of new insect applications is likely to become available, including for pest control and 
agricultural purposes. CRISPR-Cas9 based tools will also allow for easier editing of mammalian 
genomes, with most applications focusing on germline (heritable) edits. Several genome editing 
applications have already been demonstrated, including the development of cattle that were 
hornless [10], [13]. 
A published survey on patent on the CRISPR-Cas9 landscape until 2019, show a high num-
ber in patent registrations. The total number of patents in technical improvement was 1052, in 
agriculture was 374, in medical was 614 and in industry was 192 [33]. This could boost various 
biotech products generated by genome editing employing CRISPR-Cas9 to make the genetic en-
gineering of plants, animals, microorganisms and human therapy much more efficient [18], [22]. 
A number of research firms have published market projections for gene editing products using 
CRISPR-Cas9 and other technologies. Application areas include human therapeutics, research 
tools, crops, livestock, yogurts, cheeses, and more. In August 2018, Ireland-based Research and 
Markets estimated that the global market for gene editing will grow at a compound annual 




growth rate (CAGR) of 33.26% from US $551.2 million in 2017 to US $3.087 billion in 2023. Zion 
Market Research estimated that the CRISPR-Cas9 gene editing market in 2017 was US $477 mil-
lion and projected that it will reach US$4.271 billion by 2024, a CAGR of 36.8%. A February 2017 
projection by the U.S.- based market research firm Grand View Research anticipates the global 
market for gene editing products will reach US $8.1 billion by 2025 [16]. 
In the near future, it is predicted that the market based on genome editing will be 
stronger, since the industry relies on the availability of tools and platforms of genome editing 
technology that are constantly progressing. There are many companies and other entities that 
provide genome editing (especially CRISPR-Cas9) constructs, reagents, and tools. However, 
there are other areas where genome editing may also have significant economic impacts includ-
ing bioeconomic which is very important and can be used as strategic tools for facing challenges 
such as population growth, climate change, increasing greenhouse gas emissions, and need for 
food and water. Bioeconomic is expected to increase resilience food, produce healthier food, 
and reduce negative environmental impacts from the agricultural, marine and manufacturing 
industries. Bioeconomic can also assist in the world’s switching from fossil sources for energy 
needs and industrial raw materials to more sustainable sources [34]. 
4. Opportunities and Challenge in Indonesia 
a. Research and Capacity 
Genome editing is one of the strategic technologies to support the national strategic plans 
in which involve food resilience, energy resilience, environment protection and health. It be-
comes more significant since the technologies already proven in many countries fo more than 5 
years. Therefor development of genome editing must be a mainstream. National capacity right 
now become better both the human resources and research facilities. Experiences during han-
dling Covid-19 many institutions facilitated with better equipment with various equipment 
which working on molecular biology. Some research activities about genome editing have al-
ready been carried out in many research centers such as Biotechnology Research Center-LIPI, 
BBBiogen-Ministry of Agriculture, Gadjah Mada University, the Indonesian Center for Biotech-
nology and Bioindustry Research, etc. Research activities mainly dealing with plants such rice, 
chili, artemisia, citrus, palm oil, cassava for various superior properties. 
Bahagiawati et al. [3] reported about the research progress on genome editing and the 
necessary regulation for genome editing. Research related to genome editing applications, es-
pecially those using the CRISPR-Cas9 technique, has also been initiated in Indonesia. For exam-
ple, the application of CRISPR technology has been tested to overcome the biotic stress of 
ganoderma disease in palms [8] and accelerate flowering in orchids [28]. Several research insti-
tutions that have conducted pilot research using genome editing techniques include the Agri-
cultural Research and Development Agency (ICABIOGRAD) [39], the Indonesian Biotechnology 
and Bioindustry Research Center (PPBBI) [8], The Indonesian Institute of Sciences (LIPI) and Gad-
jah Mada University (UGM) [28]. Genome editing research activities with CRISPR-Cas9 that are 
being carried out at ICABIOGRAD include improving rice plants for semi dwarf properties, re-
sistance to bacterial leaf blight, and increasing the number of grains [39] [40]. A basic research 
on rice about molecular and phenotypic analyses of Rice Inpari HDB/K15 F2 lines containing 
much efficient mutant gene resulted from genome editing method is recently also reported [27]. 
In addition, ICABIOGRAD also carries out genome editing on citrus, chili and artemisia plants 
respectively for huang long bing (HLB) resistance, Gemini virus resistance, and high artemisin 
levels [5]. At the Research Center for Biotechnology-LIPI, in collaboration with Kyoto University, 




currently, the roles of transcription factors in lignin biosynthesis in rice are being investigated. 
In the meantime, the Indonesian Biotechnology and Bioindustry Research Center are focusing 
on combating diseases reducing the productivity of oil palm. 
 
b. Consideration for Regulation 
Government Regulation on genetically modified organisms was established on the basis 
of the precautionary approach in accordance with the Cartagena Protocol on Biosafety. This 
Protocol has been ratified by Indonesia by Act No. 21/2004. In this regulation, it has been deter-
mined that every person who conducts research and development on biotechnology products 
must prevent and / or overcome the negative impact of its activities on human health and the 
environment. The regulation for the release of biotechnology products (microbes, plant, fish, 
animal) is available in Indonesia as stipulated in the Government Regulation (PP No. 21/2005). 
Due to its superiority and relative simplicity in its application, in the future research and 
application of genome editing techniques in Indonesia are predicted to play important roles and 
can encourage new breakthroughs in the development of new seeds, products and processes 
that can boost the bioeconomy and the national competitiveness. Genome editing requires a 
genetic engineering process for editing the genome, however the products obtained can have 
similarities with the results of natural mutations. So that after validation using the molecular 
biology approach it can be categorized as non-GMO. 
The types of genome editing results are commonly known as SDN1, SDN2 and SDN3 de-
pending on the mechanism of repair process of the target DNA cut by the DNA nuclease enzyme; 
either independently repaired by non-homologous end joining/NHE (SDN1), or with a template 
for introducing repair of the base sequence (SDN2) or with a template for integrating sufficiently 
long DNA fragments (knock-in) (SDN 3) via homologous recombination. SDN 1 can be catego-
rized as non-GMO, while SDN2 and SDN3 can be categorized as non-GMO depending on the final 
results. The Focus Group Discussion (FGD) held in LIPI Cibinong 28 February 2020 which was 
attended by representative from Research Institutions, regulators and international expert con-
cluded that the genome editing of SDN 1, SDN 2 and SDN 3 which are classified as non- GMO 
should be determined separately from GMO by the National Committee on Biosafety (KKH). 
Furthermore, the FGD recommend that KKH conduct a review of PP21 / 2005 concerning Bi-
osafety of GMO on its suitability with the latest technological developments such as genome 
editing. 
 
c. The role of genome editing for bioeconomy of Indonesia 
According to Conservation International (CI), Indonesia belongs to Megadiversity Coun-
tries which has 20% of the 1,605 bird species (323 species) and 53% of the world's 720 mammal 
species (382 species) that are found to live naturally in the territory of Indonesia. In relation to 
ecosystem, Indonesia also has 19 types of natural ecosystems which are scattered in various 
regions from Sumatra to Papua. Moreover, as an archipelagic country, Indonesia has a coastline 
of not less than 95,181 km2 which is surrounded by tropical seas, thereby increasing the high 
level of biodiversity. 
The potential of biodiversity will strengthen the bioeconomy of Indonesia. Biodiversity 
has very significant roles for human life and the environment, among others, as a source of food 
and medicine, a place for water reserves (reservoir), maintaining the carbon cycle and the 
source of useful traits. It is estimated that contribution of the biodiversity to bioeconomy in the 
form of food sources from terrestrial, semi terrestrial and marine ecosystems, in the form of 




food biomass, which consists of food crops, vegetable crops, fruit crops, plantation crops and 
biomass from livestock and livestock right is Rp. 1,334.7 trillion (in 2012) in total value. Bio-
pharma-plants (approximately 449,300 tons) for the provision of medicinal, health and cosmetic 
ingredients in 2012 contributed a total value of Rp. 4 trillion. Those were underestimated values 
because the overall contribution of biopharmaceuticals, especially those from household busi-
nesses, may not be recorded since there is no official data. Furthermore, energy supply services, 
in the form of biomass for energy (18.4%) and for hydrothermal energy sources (2.1%) have an 
economic contribution value of Rp. 336.88 trillion (equivalent to USD oil price. 112.7/barrel. 
Meanwhile, for plants that provide varieties of wood for building, plant sap for rubber and other 
adhesive industrial materials, contributed to a value of Rp. 1,081.26 trillion to the economy [4]. 
Genome editing technology which is already proven in many countries will be key driving 
factors to make various process and products. The value of biodiversity will be increase both for 
our own needs and for exports. In addition, genome editing can also be utilized to develop pro-
cesses to rehabilitation of damaged environment, develop green material, green energy and 
green manufacturing processes, as well as pharmaceutical products and health care. 
5. Conclusion 
To support bioeconomy, genome editing could play a key role in various goals to develop 
effective and efficient processes for manufacturing product and services. Genome editing as the 
basis for numerous processes can be combined with bioinformatics, nano technology and other 
state of the art technologies. Implementation of genome editing will be able to strengthen food 
resiliency, energy resiliency, feed products, fiber products, pharmaceutical products and chem-
ical products which are environmentally friendly, and human therapy. The conversion of poten-
tial biodiversity to more valuable products and services will create new jobs and new businesses. 
The bioeconomy of Indonesia will be nurtured by the development of genome editing technol-
ogy. To accelerate the implementation of genome editing, however, appropriate regulations are 
needed. 
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